×

Cramer's Mad Dash: Sarepta is 'Russian roulette'

9:23 AM ET Tue, 12 Nov 2013

Jim Cramer explains what to watch ahead of the open, including Sarepta which is being told by the FDA not to proceed with its DMD drug.